Coloplast A/S (OTCMKTS:CLPBY) Short Interest Down 99.5% in March

Coloplast A/S (OTCMKTS:CLPBY) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 2,600 shares, a decline of 99.5% from the February 29th total of 546,900 shares. Based on an average daily volume of 105,600 shares, the days-to-cover ratio is presently 0.0 days.

Coloplast A/S Price Performance

Coloplast A/S stock traded up $0.04 during midday trading on Thursday, reaching $13.55. The stock had a trading volume of 71,357 shares, compared to its average volume of 62,879. Coloplast A/S has a 1-year low of $9.90 and a 1-year high of $14.77. The firm’s fifty day simple moving average is $12.78 and its 200-day simple moving average is $11.61. The company has a quick ratio of 0.35, a current ratio of 0.53 and a debt-to-equity ratio of 0.76.

Coloplast A/S (OTCMKTS:CLPBY) last issued its earnings results on Friday, February 9th. The company reported $0.08 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.08. Coloplast A/S had a net margin of 19.48% and a return on equity of 43.30%. The business had revenue of $953.60 million for the quarter. Research analysts forecast that Coloplast A/S will post 0.35 EPS for the current fiscal year.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.